65,437 trials
Dry Eye
Primary: The Percentage of Subjects at Month 3 With Corneal Sensitivity < 50 Millimeters (mm) at Any of the Locations Measured — 13; 13; 21.7; 13 Percentage of Subjects
Sore Throat Due to a Common Cold
Primary: Change From Baseline Sore Throat Pain Intensity — -27.4; -26.9 mm
Impaired Glucose Tolerance · Obstructive Sleep Apnea
Primary: Number of Subjects With Normalization of Impaired Glucose Tolerance (IGT) — 7; 5 subjects — p=0.57
SURGICAL SITE INFECTION
Primary: Surgical Site Infection — 6; 3 participants — p=<0.05
Arrhythmias, Cardiac
Primary: Procedure-related Complications Rate Requiring Resolution by Surgical Intervention — 2 participants
Kaposi's Sarcoma · HIV Infections · HIV Seronegativity
Primary: Response Rate — 31 Percentage of participants
Crohn's Disease
Primary: Mean Cost Per Participant of Consultations With Health Care Providers (HCPs) — 913.48; 962.30; 1317.58; 1664.45 Pounds sterling per participant — p=<0.0001
Gaucher Disease
Primary: Change From Baseline in Spleen Volume Measured by MRI. — -26.91; -38.01 percentage of change — p=<0.0001
Ischemic Stroke
Primary: Technical Device Success by as Assessed by the Percentage of Participants Which Established at Least TIMI 2 Flow Upon Deployment of the System Across the Occlusion and…
Bronchiectasis
Primary: Ratio of Absolute Neutrophil Count at End of Treatment Compared to Baseline — 1.08; 1.01 ratio
Cystic Fibrosis
Primary: Ratio of Sputum Absolute Neutrophil Count at End of Treatment Compared to Baseline — 1.07; 1.10 ratio
Chronic Obstructive Pulmonary Disease (COPD)
Primary: AWT-Pi10 (Airway Wall Thickness of a Theoretical Airway With an Internal Perimeter of 10 mm) — 3.84; 3.83 mm
Skin Cancer · Basal Cell Carcinoma · Squamous Cell Carcinoma
Primary: Skin Carotenoid Levels in Subjects With History of Squamous Cell Carcinoma Versus Control Subjects — 27,635; 31,219 Raman spectroscopy intensity counts — p=0.31
Allergic Conjunctivitis
Primary: Change From Baseline in Patient-Assessed Ocular Itching, Environmental Exposure Chamber (EEC), at 3 Hours — -1.63; -1.11 Units on a scale
Healthy
Primary: Plasma Dipyridamole Maximum Concentration (Cmax) — 2750; 2550; 2550 nanogram/milliliter